Verastem Oncology
VSTM
C$7.24
Share price
-5.85%
Change (1 day)
51.93%
Change (1 year)
Categories
Verastem Oncology (VSTM) - Total assets
Total assets on the balance sheet as of March 2025 : C$0.17 Billion
According to Verastem Oncology 's latest financial reports the company's total assets are C$0.17 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Verastem Oncology - Total assets on balance sheet (from 2011 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | C$0.19 B | 53.96% |
| 2022-12-31 | C$0.12 B | -6.86% |
| 2021-12-31 | C$0.13 B | -29.63% |
| 2020-12-31 | C$0.19 B | 3.89% |
| 2019-12-31 | C$0.18 B | -49.84% |
| 2018-12-31 | C$0.37 B | 234.53% |
| 2017-12-31 | C$0.11 B | 0.45% |
| 2016-12-31 | C$0.11 B | -28.36% |
| 2015-12-31 | C$0.15 B | 37.04% |
| 2014-12-31 | C$0.11 B | -14.14% |
| 2013-12-31 | C$0.13 B | 44.3% |
| 2012-12-31 | C$92.4 M | 53.87% |
| 2011-12-31 | C$60.05 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Curis CRIS | C$53.61 M | -70.14% | 🇺🇸 USA |
 Pfizer PFE | C$283.63 B | 157,858.36% | 🇺🇸 USA |
 LabCorp LH | C$24.00 B | 13,266.79% | 🇺🇸 USA |
 GlaxoSmithKline GSK | C$107.08 B | 59,537.88% | 🇬🇧 UK |